Scott S. Tykodi MD of Seattle Cancer Care Alliance notes that the data from Checkmate 214 is clear that overall high grade side effects are better with immunotherapy.
Scott S. Tykodi MD of Seattle Cancer Care Alliance notes that the data from Checkmate 214 is clear that overall high grade side effects are better with immunotherapy.